Using ‘Surfaceomics’ as a Jumping Point, a Case is Made for Clinical Lab Growth
Arun Wiita from USCF details his lab’s work using mass spectrometry
Already a member? Log in here
Author Information
Scott Wallask
Scott Wallask is senior editorial manager at G2 Intelligence and its sibling brands, The Dark Report and Today’s Clinical Lab. During his 30-year career, he has covered the clinical lab, healthcare, and high-tech markets during stints at TechTarget, HCPro, ZoomInfo, and the SAPinsider family of online publications. A former newspaper reporter, he graduated from Northeastern University with a bachelor’s degree in journalism. He can be reached at swallask@clinicallab.com.
Posts by the Author
CMS-lcaCMS-lirCMS-nirCoding-lcaEssentialFee Schedules-lirFee Schedules-nirLab Industry AdvisorReimbursement-lcaReimbursement-lirJanette WiderScott Wallask
Software as a Medical Service, or SaMS, Takes Spotlight in New CMS Proposal
Clinical labs have until Aug. 31 to submit public comments about the anticipated changes
Already a member? Log in here
Coding-lcaEssentialLab Industry AdvisorReimbursement-lcaReimbursement-lirReimbursement-nirScott Wallask
Six RCM Tips from the ADLM 2026 Meeting
Watch for panel unbundling, Medicare spending shifts, and frequency-based denials
Already a member? Log in here
Carbon Impact Report Shows Growing Lab Commitment to Reducing Carbon Emissions
Life sciences and clinical laboratories are accelerating zero-carbon goals, says My Green Lab CEO
Already a member? Log in here
Compliance-lcaDOJ-lcaDOJ-nirEnforcement-lcaEnforcement-lirEnforcement-nirEssentialFalse Claims-lcaLab Industry AdvisorScott Wallask
Lessons in Laboratory Compliance from a $30 Million Settlement
‘Lean lab’ setup appears to have caught the eyes of investigators
Already a member? Log in here
Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Roche acquires a workflow rather than a company, says AI industry observer
Already a member? Log in here
CLIA-lcaCLIA-nirCMS-lcaCMS-lirCMS-nirEssentialFDA-lcaFDA-lirFDA-nirLab Industry AdvisorLegislation-lcaLegislation-lirLegislation-nirScott Wallask
New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
CLIA-lcaCLIA-nirCMS-lcaCMS-lirCMS-nirCompliance-lcaCompliance-nirEssentialLab Industry AdvisorScott Wallask
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
CLIA-lcaCLIA-nirCMS-lcaCMS-lirCMS-nirEnforcement-lcaEnforcement-lirEnforcement-nirEssentialHealth care reform-lirLab Industry AdvisorLegislation-lcaLegislation-lirLegislation-nirPAMA-lirReimbursement-lcaReimbursement-lirReimbursement-nirScott Wallask
Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
